Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. TOCO 500 mg (alpha-tocophérol)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

TOCO 500 mg (alpha-tocophérol)

Medicine - Posted on Sep 15 2004 - Updated on Jun 12 2019
Active substance (DCI)
  • alpha-tocophérol
history (2)
  • 9/15/04

    TOCO 500 mg (alpha-tocophérol)

    TOCO 500 mg (alpha-tocophérol)
    icône flèche
  • 5/21/03

    TOCO 500 mg (alpha-tocophérol)

    Avis favorable à l'inscription sur la liste des spécialités remboursables aux assurés sociaux et sur la liste des médicament...
    icône flèche
Technical information
Manufacturer
PHARMA 2000
Presentation

TOCO 500 mg, capsule molle
B/30 code CIP : 3264550

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
4GWF2ppHta0DEwhY